Introduction
The anticoagulants market is increasingly influenced by emerging markets and regional investment opportunities. Pharmaceutical companies are recognizing the potential in developing economies where cardiovascular disease prevalence is rising and access to anticoagulant therapy is expanding. Strategic investments in infrastructure, local manufacturing, distribution networks, and...